NICE CG191 recommends severity assessment using CRB-65 to guide site-of-care and antibiotic choice) Doxycycline or clarithromycin (alternatives) For inflammatory bowel disease , where sulfasalazine (contraindicated in sulphonamide allergy per SmPC) might otherwise be used, alternatives include: Mesalazine (5-aminosalicylic acid without the sulphonamide component) Balsalazide or olsalazine (other 5-ASA derivatives) (NICE NG129 for Crohn's disease
Frequency: Once per day (subcutaneous), ideally 3060 minutes before bedtime
Coming off a GLP-1 may trigger fears of losing that version of yourself or returning to an old identity you worked hard to escape
(Call out charge applicable)
[1] [2] However, retatrutide has not yet received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it does not hold a UK marketing authorisation
However, whether LC ameliorates adverse effects induced by high-fat diets (HFD) through regulating ER stress is still unknown
